Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Lemaitre Vascular (LMAT) over the last 17 years, with Q3 2025 value amounting to -$343.1 million.

  • Lemaitre Vascular's Enterprise Value fell 17690.51% to -$343.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$343.1 million, marking a year-over-year decrease of 17690.51%. This contributed to the annual value of -$299.7 million for FY2024, which is 18524.85% down from last year.
  • Per Lemaitre Vascular's latest filing, its Enterprise Value stood at -$343.1 million for Q3 2025, which was down 17690.51% from -$319.5 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Enterprise Value registered a high of -$21.8 million during Q2 2021, and its lowest value of -$343.1 million during Q3 2025.
  • Its 5-year average for Enterprise Value is -$130.3 million, with a median of -$90.2 million in 2023.
  • Its Enterprise Value has fluctuated over the past 5 years, first soared by 2250.01% in 2021, then tumbled by 24787.19% in 2022.
  • Over the past 5 years, Lemaitre Vascular's Enterprise Value (Quarter) stood at -$70.0 million in 2021, then fell by 18.2% to -$82.7 million in 2022, then dropped by 27.07% to -$105.1 million in 2023, then tumbled by 185.25% to -$299.7 million in 2024, then fell by 14.46% to -$343.1 million in 2025.
  • Its Enterprise Value stands at -$343.1 million for Q3 2025, versus -$319.5 million for Q2 2025 and -$302.5 million for Q1 2025.